The IL-3 receptor α chain (IL3RA; CD123) regulates the proliferation and differentiation of HSPCs (Emerson et al., 1988), is often expressed on AML LSCs and blasts from relapses (Jordan et al., 2000), and hence is associated with a poor outcome of the disease. This evidence concerns the gene IL3RA and acute myeloid leukemia.